ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)

News

Is Suvretta's Stake Cut and FDA's Pediatric Review Acceptance Altering The Investment Case For Arcutis Biotherapeutics (ARQT)? [Yahoo! Finance]
Arcutis Stock Is Up 100% in a Year but Here's Why One Fund Still Sold 1 Million Shares [Yahoo! Finance]
This Biotech Stock Could Cure Your Portfolio's Pain [Yahoo! Finance]
Assessing Arcutis Biotherapeutics After 99% YTD Surge and Mixed Valuation Signals [Yahoo! Finance]
Arcutis Biotherapeutics (NASDAQ:ARQT) was upgraded by analysts at Wall S
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com